Bert J. Quint: A Leader Who’s Changing the Way the World Heals

 

Wound management is a vital and evolving discipline within healthcare, addressing both acute and chronic wounds with advanced technologies, specialized treatments, and multidisciplinary care. With over 60 million people affected globally each year, the demand for effective, patient-friendly, and sustainable solutions has never been more urgent. Visionaries in this field are reshaping outcomes for patients while easing the strain on healthcare systems—and Bert J. Quint is at the forefront of this movement.

As the Founder and CEO of DEBx Medical, Quint leads a company known for its disruptive innovation in wound care. His journey from biochemist to healthcare entrepreneur is grounded in a mission to deliver life-changing outcomes and reduce the burden of chronic wounds. Through pioneering approaches that eliminate infections without antibiotics and drive sustainable healing, Quint and his team are transforming how the world heals.

---

A Mission Born from Collaboration and Passion

Quint’s venture into wound care began with a shared vision alongside Professor Carlo Bignozzi and Dr. Alberto Cogo. Together, they developed a novel method capable of disrupting deep-tissue biofilms—a breakthrough that changed non-healing wounds into granulating, epithelizing wounds after a single treatment. Quint recalls, “Our method worked and transformed wounds that had not responded to any therapy.” Backed by continuous support from his wife Petra, this innovation laid the foundation for DEBx Medical.

Motivated by the immense cost and suffering caused by chronic wounds, Quint focused on addressing root causes without relying on antibiotics—thereby avoiding complications like resistance. He believes healthcare must shift “from procedures to outcomes and from cost to value,” and this philosophy fuels DEBx Medical’s approach to delivering both effectiveness and affordability.

---

Disruptive Innovation in Action

DEBx Medical’s core innovation is a treatment that eliminates infections in non-healing wounds—without the need for antibiotics in over 94% of cases. It acts broadly against all bacterial and yeast strains, including MRSA, and typically requires only one application. This has changed lives, as seen in the case of a 93-year-old woman in Spain whose 16-year venous ulcer healed completely within two months of treatment.

Rather than competing with existing therapies, DEBx complements them. Whether it’s skin grafts or negative pressure wound therapy (NPWT), their method enhances the efficacy of other products. “We are not a competitor; we are complementary,” says Quint—positioning DEBx as a vital collaborator in the global wound care ecosystem.

---

Technology-Driven, Patient-Centered

Chronic wounds are not just a clinical challenge—they’re an economic one. In the U.S. alone, the cost rivals the five most expensive cancer treatments combined. DEBx Medical addresses this through high-impact, cost-effective solutions powered by emerging technologies.

Artificial intelligence and real-time tissue analytics are central to their strategy. Collaborating with Swiss-based IMITO, they’re developing AI-driven tools to support clinical decision-making and optimize treatment timelines. “AI will allow faster, more efficient wound healing,” says Quint, signaling a data-informed future for wound care.

---

Leading with Vision, Empowering Talent

Quint’s leadership is rooted in collaboration and creativity. Drawing from his experience with major U.S. companies, he brings together diverse, dynamic minds to solve complex healthcare challenges. “I surround myself with young, smart, driven people,” he shares, fostering a culture where ideas flourish and innovation thrives.

This leadership ethos extends to talent development. Many of DEBx Medical’s first employees have grown into leaders in their own right—a testament to Quint’s belief in giving individuals the space and mentorship to succeed. He credits his long-time partners Bignozzi and Cogo for cultivating an environment of open reflection and learning, driving constant improvement.

---

Building for the Future

Quint has bold ambitions: to fundamentally reshape global wound care. With rising diabetes rates and an aging population, chronic wounds are set to become even more prevalent. “Twenty-five percent of diabetic patients will develop chronic wounds, and a quarter of those risk losing a limb,” he warns. The company is accelerating development on new solutions, including reinfection prevention tools, wound fillers, and an over-the-counter version of their current therapy.

Their impact, however, goes beyond medicine. Sustainability is a core pillar of DEBx Medical’s operations. Their main product is fully biodegradable—“a happy accident,” as Quint describes it. The company is also investing in greener manufacturing and supply chain practices, as well as energy-efficient R&D methods, reinforcing their commitment to both environmental and human health.

---

Rooted in Purpose, Driven by Results

For Quint, the mission is personal. Witnessing a patient’s nine-month-old wound begin healing within 48 hours of treatment changed everything. “That was the moment I knew I had to dedicate myself fully to this,” he says. His advice to aspiring healthcare innovators? “Focus on solutions that truly make a difference. Grow a thick skin. Choose the right people and partners. And never lose sight of the patient.”

That patient-centered approach defines DEBx Medical. Their treatments are not just clinically sound—they’re intuitive, accessible, and designed for real-world use. By listening to patients and caregivers, the company refines its offerings to ensure every product delivers tangible improvements in quality of life.

---

Shaping the Standard of Care

Under Bert J. Quint’s leadership, DEBx Medical is more than a company—it’s a movement to revolutionize wound care. With a steadfast commitment to innovation, sustainability, and patient well-being, Quint is changing how the world heals—one breakthrough at a time.

Lisa Wright: From Compassion to Leadership

 At the center of healthcare leadership is Lisa Wright , a veteran professional guided by a mission of compassion and a career that has been devoted to enhancing the lives of the individuals who are struggling through the intricacies of health insurance. Lisa's career path in the field of health insurance was significantly influenced by early experiences in the National Marrow Donor Program, where her spirit of compassion was given purpose.

Her commitment to healthcare increased as she devoted considerable time on behalf of patients requiring a bone marrow or stem cell transplant.  This advocacy increased her health care skill set, as a result of the immense coordination with insurance organizations.  For twenty-plus years, Lisa Wright has gained considerable professional experience in the health care sector, with an interest in government programs and underserved populations.

As an executive at WellCare in Tampa, Florida, and a regional leader for UnitedHealthcare's Texas region, Lisa Wright developed expertise in health insurance. In May 2020, inspired by her passion for creating a positive difference, she became President and CEO of Community Health Choice (Community). There, she oversees a passionate team united by a vision of improving the well-being of the underserved population, a mission dear to her.

Community Health Choice is a local, non-profit health plan that provides a variety of health insurance programs and services to our Members. As a Managed Care Organization (MCO), it provides coverage under the Children's Medicaid (STAR) and CHIP programs, and an HMO Dual Special Needs Plan (D-SNP), as well as providing plans made available through the Health Insurance Marketplace.

In this special feature, we go in-depth with Lisa's remarkable path, delving into her experiences, reflections, and the impactful role she fills at Community Health Choice.

A Leader's Journey at Community Health Choice

Lisa's entry into Community Health Choice was during a revolutionary time in the healthcare sector. Among a group of hardworking people, she shared a common mission with Community to provide healthcare services to under-served residents in Southeast Texas. Highlighting the non-medical determinants that affect health, Lisa Wright reports, "In addition to medical care, Community has a strong focus on addressing the non-medical drivers of health, understanding their role in enhancing health outcomes and reducing health disparities."

Starting her career in the midst of the COVID-19 pandemic, the initial priority was to cushion its effects for employees, patients, and health professionals. Looking back on almost four years at Community, Lisa Wright is optimistic, saying, "I am optimistic that we will find more effective ways to address the health challenges and make a positive impact on the communities we serve."

At Community, Lisa Wright led strategic growth and diversification, achieving an impressive 42 percent growth, setting a record of more than 550,000 Members, 25,000 providers, and 100 community collaborations. Lisa's staff was instrumental in addressing mental health issues through creative partnerships, like collaboration with the Harris Center for developing an inpatient center for the homeless. This facility offers an enabling environment to rehabilitate and reintegrate into society successfully, demonstrating the dedication to well-being and responding to social needs in vulnerable communities.

In her own words, "As part of my dedication to leadership development, I have initiated new leadership initiatives with an emphasis on alignment across the organization to make certain we not just excel together but also become better at the services we provide to those we serve." She invites leaders to adopt the mantra 'Run it like you own it!' 

Personalized Healthcare Solutions for Every Stage of Life

Understanding the individuality of each person's healthcare needs, Community is dedicated to offering customized solutions empowering individuals and families to succeed and live healthier lives. The variety of health insurance plans is created to support every phase of life so that complete coverage and assistance is provided:

CHIP Unborn: Pregnant women are provided prenatal care for their unborn child.

CHIP: Insurance through age 19 for those whose families don't qualify for Medicaid and cannot pay for private coverage.

STAR: Medicaid coverage through age 21 for U.S. citizens who cannot afford health coverage.

Health Insurance Marketplace: Designed for those and their families without employer-sponsored coverage.

Medicare Advantage HMO Dual Special Needs Plan (D-SNP): Only for those low-income individuals eligible for both Medicare and Medicaid, providing additional benefits without cost.

STAR+PLUS: Global coverage for adults with disabilities or seniors aged 65 years and older, integrating acute care with long-term services and support (LTSS) to foster community living.

Third-Party Administrator (TPA) – Harris Health Indigent Program: Community participation in contracting, claims administration, and provider relations for this program.

Outside of insurance plans, Community Health Choice's CareerReady initiative is instrumental in furthering the Medicaid mission, seeking to offer a way out of poverty and upward on the economic ladder. Focusing on young adults aged 17 to 30 years old, pregnant women, high school seniors, and eligible Marketplace Members, the CareerReady scholarship subsidizes tuition, fees, and books necessary for job certification.

Adapting and Thriving

Overcoming the challenges of the COVID-19 pandemic became one of the biggest challenges for Community Health Choice. Looking back at this difficult time, Lisa Wright adds, "We adapted by utilizing Telehealth to effectively continue serving our Members throughout this crisis. We shifted the majority of our 800-member workforce to working remotely while maintaining productivity and personal obligations." 

During the pandemic, the commitment to Members did not falter. Emergency healthcare requirements were met immediately, using out-of-the-box thinking such as organizing transportation for office appointments and conducting in-home physician visits. Partnerships with Federally Qualified Health Centers helped organize immunization drives among people in communities, and an alliance with Mom's Meals made sure children had food available. Immunizations for kids and visits to elderly people were given high priority. In the midst of the challenges, the commitment to delivering uninterrupted service to more than 550,000 Members continued.

Lisa Wright points out, "The pandemic presented challenges but also made us reconsider our work approach. We pursued a hybrid office setup, offering our employees options for working remotely and in the office." This approach not only provided flexibility but also put the onus on employee engagement. As it evolves, Community Health Choice is poised to move to a new office located in the center of Houston. Designed to foster collaboration, communication, hoteling space, and employee well-being, the office is reflective of the organization's focus on resilience and flexibility.

Embracing Innovation for Improved Member Experience

In its commitment to providing excellent service to its Members, Community Health Choice continually seeks technological alternatives that make plan administration more efficient, save time, and are more convenient for Members.

Lisa Wright points out, "This year, we introduced our Member mobile app. This app gives access to benefits from a user's smartphone or tablet any place, any time." The app enables Members to see coverage plan information, find a doctor, review claims and authorizations, get notices, and more.

Community Health Choice continues its virtual care promise by offering several services such as Telehealth and a virtual-only product. Telehealth allows Members to speak with a physician for their everyday health issues 24/7, accessible anywhere using phone, web, or mobile app. Members may order or refill prescriptions and obtain guidance from healthcare professionals prior to visiting an ER or urgent care center.

In the future, Community is set to adopt cutting-edge technologies, especially with artificial intelligence (AI). Lisa Wright observes an emerging trend across the healthcare industry where AI is being used to review the need for prior authorizations, a radical change in relationships among health plans and healthcare providers.

AI integration automates the evaluation of incoming authorization requests. AI makes a detailed evaluation, establishing the sufficiency of clinical documentation against the specifications of mandatory authorization. Lisa Wright points out that AI-based recommendations simplify the authorization process, with improved overall efficiency.

Lisa Wright's vision is, "The adoption of this technology will free our staff from routine tasks, giving them the ability to improve their skills and concentrate on mission-critical activities."

Pioneering Progress

In its steadfast dedication to providing superior services, Community Health Choice aggressively undertakes ongoing research and development (R&D) activities in a bid to comprehend changing health needs in the community. Lisa Wright emphasizes, "Our goal is to better understand the changing health needs of our Members," highlighting the importance of these assessments in informing Member benefits in a better alignment with distinctive needs.

Strategically utilizing Member information, Community positions itself to anticipate and respond to changing needs and behaviors. Lisa Wright highlights continued R&D efforts, such as the assessment of children's mental health, nutrition's effect on pregnancy, and research aimed at non-medical determinants of health (NMDOH).

To tackle children's mental health, Community has teamed up with futuresTHRIVE and integrated TweenScreen mental health screening software. This easy-to-use application, based on sound research sources, actively identifies potential mental health threats in children, providing helpful information for healthcare professionals and parents.

In reaction to sobering data on black maternal health disparities, Community partners with Harris Health in the ACCESS Black Maternal Health program, which seeks to mitigate the risk to black women at birth and infant mortality. Lisa Wright clarifies, "This disparity is partly due to poor care before, during, and after pregnancy."

Community's commitment to advancing services is extended to a collaboration with ProgenyHealth, offering maternity care management services in their entirety. The co-branded Community/ProgenyHealth app offers Members persistent, connected support throughout their parenting experience, advancing optimal maternal and infant health.

To address the widespread mental health issue, Community works in conjunction with the Harris Center to provide a specialized inpatient center for the homeless. This center transcends traditional measures, promoting rehabilitation and successful integration into society.

In a major milestone, Community Health Choice achieves interim NCQA accreditation, reflecting its dedication to improving Member health outcomes. As the state's lone dually accredited health insurance plan, in addition to current URAC accreditation, Community establishes a high standard of quality healthcare in Texas, reaffirming its commitment to excellence.

Building a Bright Future

In providing advice to future healthcare professionals, Lisa Wright stresses the need to be ready for challenging, dynamic issues that require creative and cooperative answers. She emphasizes the necessity for a strong passion for enhancing the health and well-being of varied populations and meeting the social and environmental determinants impacting them.

To be successful in the healthcare industry, Lisa Wright recommends developing a strong leadership, vision, and sense of responsibility, combined with lifelong learning and professional growth. Upcoming professionals are urged to take active steps towards increasing their knowledge and expertise in healthcare economics, policy, management, and delivery. Establishing networks with like professionals and stakeholders who have the same goals and values is also important

She also relates, "My advice to potential leaders is to channel your energy into what you can manage; the rest is gravity." Emphasizing the need to develop good relationships for sustainability in the long run, Lisa Wright highlights the usefulness of investing in people and developing a team of skilled professionals. Knowing that each day is a learning day, Lisa tips future leaders not to feel obligated to have all the answers, stressing the importance of employing the best and brightest workforce.

When dealing with challenges, Lisa Wright encourages adopting the mindset that there is always an alternative and a "no" can even be considered as delay instead of rejection.

Next Chapter in Healthcare

In an important move toward increasing the health and well-being of underserved Texans, Community Health Choice is pleased to add the Texas STAR+PLUS program to its 2024 plan offerings. Designed specifically to offer life-saving Medicaid managed-care services to those with disabilities and individuals 65 and older, generally among the most vulnerable in our communities, Lisa Wright points out, "The STAR+PLUS program will enable Community to reach an additional segment of the population."

The roll-out of the STAR+PLUS plan is a landmark expansion, symbolizing Community's dedication to creating healthier lives for everyone. More than just insurance coverage, the overall goal is to provide extensive long-term services and support that are tailored to the specific needs of participants in the program.

Lisa Wright underscores, "We will adopt a more intensive service-coordination model to maximize care and delivery, in alignment with the individualized needs of each Member." Redesigning Member benefits to optimize alignment with individual needs; Community uses Member information to proactively anticipate needs and behaviors in order to maximize tailoring and effectiveness of care.

Placing emphasis on prevention strategies, such as vaccine encouragement, environmental health issues resolution, and resolution of non-medical determinants of health (NMDOH), Community Health Choice seeks to raise its proactive role. Through advanced Member data, the organization effectively identifies Members needing preventive interventions or support in resolving NMDOH, avoiding sickness and health decline.

Lisa Wright sees Community's future with greater focus on meeting NMDOH through digitalized operation and incentive models. Data is critical in determining required benefit increases to meet certain NMDOH factors, further testifying to Community Health Choice's dedication to global, personalized, and effective healthcare for its Members.

Mohamed Galal: Enhancing Regional Healthcare Growth and Innovation

What's next? It's something that never ceases to run through the mind of a real leader – especially in an industry as fast-changing and important as that of healthcare. For the leaders running organizations within this sector, anticipating is not a choice; it's the center of it. The next discovery, the next partnership, the next way of making a concrete positive impact to more people – that is the scope of interest. And for Mohamed Galal , Vice President, Head of Middle East, Bayer Consumer Health, that visionary approach has created a career of over three decades.

With a background in pharmaceuticals and a strong focus on people, Mohamed's path is founded on growth, purpose, and results. From Cairo University to being a regional manager in one of the world's biggest and most respected health care companies, he has been driving changes that have borne positive results and a vision that goes beyond corporate spaces.

Working at Bayer, he's spearheading Middle Eastern healthcare transformation – not only with products, but with strategy, access, and profound insight into local community needs. Led by the "Health for All, Hunger for None" mission, Mohamed Galal's efforts are aimed at delivering improved health outcomes to millions, and toward building a more responsive, inclusive, and future-ready system.

Let's continue reading to learn about Mohamed's journey, vision, and fearless steps changing healthcare in the Middle East!

Mohamed Galal's Professional Journey

Mohamed Galal started his journey in healthcare with a background of academic excellence from studying at Cairo University, laying the foundation for a successful career in the pharmaceutical sector. In the past 30 years, he has established himself by his intricate knowledge of the health care industry, prioritizing business growth, market strategy, and operational accuracy. He describes, "I have accepted this industry with deep responsibility. The 30-year dedicated journey in multiple roles has formulated my comprehension and enthusiasm for this essential sector."

Through the years, he has risen through the ranks in different organizations, developing a broad range of perspectives on the complexities of the healthcare sector. His career with Bayer started with a strong focus on redefining the firm's strategy in the Middle East, where he now leads the consumer health segment. In this role, he spearheads efforts at innovation and growth for the company, leaving a lasting legacy in the region. Looking back on the development his team has made at Bayer, Mohamed Galal comments: "Each day, I am inspired by being able to drive growth and innovation through strategic initiatives." 

His job is not merely one of business success; it is one of making a positive difference in individuals' lives. "I strongly believe that through a strategic, customer-focused methodology, we can create high-quality solutions that not only address the changing needs of our communities but also improve their overall health and well-being," he continues. Mohamed Galal sees his role as leadership as one of more than mere business target achievement. He is committed to being an agent for good, making healthcare more accessible and effective in the region.

Bayer's Mission in the Region

Vice President and Head of the Middle East Mohamed Galal has a very distinct vision of Bayer's mission in reshaping healthcare in the region. This vision is in complete sync with the global mission of "Health for All, Hunger for None," which he has entrenched in his own leadership philosophy, which directs the company's every move in the region. He explains this task as one that aims to build a healthcare ecosystem that focuses on accessibility and equity so that everyone receives the benefits from the advances in the healthcare sector, irrespective of their location.

For Mohamed Galal, access is not only about delivering products, it's about building the healthcare system as a whole. He highlights the value of collaborating with policymakers and regulators to create a favorable healthcare environment that inspires innovation and addresses community needs. "We acknowledge the value of a supportive policy and regulatory environment to encourage innovation and expansion," he says.

In addition, Bayer's activities in the region spur economic growth by enhancing public health, which subsequently increases productivity. "A healthier population leads to higher productivity within the workforce, ultimately contributing to economic development within the region," he continues, emphasizing the linkage between health and regional prosperity overall. The company's activities extend beyond the enhancement of health outcomes -they are an investment in the long-term well-being of the region.

Innovative Solutions for Regional Health Challenges

Bayer has long been pioneering pharmaceutical innovation, and in the Middle East, this endeavor has taken the form of effective initiatives tackling some of the most significant health challenges in the region. These include challenges such as cardiovascular diseases, diabetes, oncology, and ophthalmology. For Mohamed, these issues are personal, and he is especially proud of Bayer's contribution towards overcoming them. One of the initiatives that impresses him most is its backing for the government's "Protect Your Heart" campaign for increasing the level of awareness about cardiovascular health.

"This campaign is critical in making consumers aware of heart health and the need for early detection," he says. Cardiovascular conditions and diabetes are two of the biggest health issues in the region, and early detection can be a lifesaver. Through such programs, it aims to empower individuals to become responsible for their own health by equipping them with information and resources to effectively manage their well-being. This is just one instance of how the company, under Mohamed Galal's leadership, has been revolutionizing the healthcare sector in the region.

Overcoming Healthcare Challenges in the Middle East

The Middle Eastern healthcare sector, although changing, continues to experience many challenges. One of the most important barriers in the region is the variation in healthcare services compared to mature markets. He says, "While the healthcare sector in ME is striving to see the availability of healthcare services, it continues to lag behind achieving per capita equivalence in relation to developed markets." Gaps in service availability and accessibility continue to be a major issue despite progress.

One of the main challenges in tackling these problems is the ignorance. A large number of people in the region are not aware of the significance of preventive care and early screening, and consequently, chronic diseases are diagnosed in their later stages. Bayer is tackling this problem by spreading awareness and bringing health services closer to the people. "We are proactively initiating programs aimed at promoting awareness and improving access to basic health care," Mohamed Galal points out. Through partnerships with healthcare institutions and governments, Bayer is helping to bridge these gaps and ensure individuals get the care they require when they require it.

Also, local production is part of its plan to increase accessibility within the region. He highlights the significance of localization in improving the efficiency and responsiveness of healthcare towards the needs of the population. "By investing locally in manufacturing, we are making sure that high-quality healthcare solutions are easily accessible to the populations we serve," he says. Not only does this make products easily accessible, but it also contributes to the development of the region's economy.

Utilizing Technology for Improved Healthcare

Technology is now playing a more critical part in defining the future of healthcare. At the vanguard of this change are digital health and artificial intelligence, and Bayer is embracing these technologies to improve patient care as well as operational effectiveness. The organization has made investments in digital health platforms that offer patients useful tools for managing their health, such as symptom-tracking and medication-adherence apps.

Mohamed Galal emphasizes the significance of utilizing AI to enhance healthcare outcomes. "We collaborate with technology firms and start-ups to assist us in embedding AI-based diagnostics and other innovative technologies into our products," he explains. One such instance is the partnership between Bayer and Huma Therapeutics to create the 'Bayer Aspirin Heart Risk Assessment' tool. This online calculator assesses the risk of cardiovascular disease without invasive testing, rendering it a priceless asset for patients in the area.

Bayer applies AI not only to patient care but also to enhancing its operations. Through the processing of huge volumes of healthcare data, it can more easily determine healthcare professionals most in need of its products. Through the use of data, the firm can reach the right persons and consequently enhance patient care, and make sure that the solutions find their way to those in greatest need.

Encouraging Sustainability in Healthcare

Sustainability is also high on the list of priorities, and the company is dedicated to ensuring that sustainable healthcare practices are promoted throughout the Middle East. That commitment goes beyond the environmental footprint of its business and touches social and economic as well. As Mohamed Galal describes, "Sustainability is a foundation of Bayer's mission, and we are strongly committed to encouraging sustainable healthcare practices throughout the region."

Bayer has ambitious sustainability goals, including a pledge to assist 100 million smallholder farmers, empower 100 million individuals with self-care solutions, and deliver modern contraception to 100 million women by 2030. In the Middle East, these objectives have helped shape focused campaigns to enhance cardiovascular health as well as deliver screenings to thousands of people. "We have effectively screened 3,000 people in 25 clinics in Iraq," Mohamed Galal explains, drawing attention to the outreach work.

The firm is also dedicated to lowering its environmental impact, such as the use of degradable materials in packaging and promotional campaigns. "By incorporating these green practices in our operations, we are not only looking to support environmental well-being, but are looking to have a positive impact on the well-being of communities," he says. 

Building High-Performing Teams and Fostering Innovation

A leader's influence is as powerful as the teams he or she assembles and the culture he or she fosters within the organization. Mohamed Galal is dedicated to assembling great performing teams and fostering an environment that promotes innovation. At Bayer, this is done through a distinctive model called Dynamic Shared Ownership (DSO), which emphasizes collaboration, customer focus, and accelerated work cycles.

"We enable our teams to work more effectively and creatively," he clarifies. Through alignment of teams around the needs of the customer, the company will be in a position to enhance response time and ensure that innovation is at the core of all they do. Mohamed Galal's management strategy also encompasses the establishment of shorter project development timelines, referred to as 90-day cycles, which enable quick feedback and correction of direction. This responsive methodology not only improves efficiency but also fosters ongoing improvement.

By fostering a culture that promotes collaboration and innovation, Mohamed Galal has made Bayer a pioneer in providing innovative health solutions. "Our mission is to leverage the scale of a multinational with the speed and agility of a start-up," he explains.

The Growth Strategy

In the future, Bayer's growth strategy in the Middle East is centered on localization, strategic alliances, and building greater accessibility for consumers. Mohamed Galal is intent on having its solutions be region-specific. That entails not just manufacturing more products locally but also poaching local talent to drive innovation and offer insight into the regional nuances of the market.

"We are dedicated to bringing and keeping local talent on board to build a workforce that has knowledge of the economic and cultural contexts of these markets," he imparts. By hiring local talent, the company is not merely building stronger operations, but it is also enabling the staff to own the success of the company.

Innovation will remain a pillar of Bayer's strategy. "Whether through new therapies, digital health solutions, or community health initiatives, we hope to offer high-quality, effective alternatives that enhance the lives of people in the Middle East," he says, highlighting the continued commitment to enhanced health outcomes in the region.

Advice for Aspiring Healthcare Leaders

As an experienced leader of more than three decades, Mohamed Galal knows a thing or two about leaving a mark in the healthcare industry. "My first piece of advice is to believe in the growth story of the industry and the region," he says.

He encourages future leaders to immerse themselves in the nuances of the healthcare industry, understand the unique needs of different markets, and build strong relationships with stakeholders. “This deep understanding will enhance your ability to lead effectively and create solutions that resonate with the people,” he advises.

He also stresses the need for integrity, teamwork, and ongoing learning as basic characteristics of successful leadership. "Foster a culture of agility and adaptability," he recommends. Adopting these attributes, future leaders can leave a lasting legacy for the healthcare industry and enhance the lives of millions of people.

Shriners Children's: Pioneering the Future of Personalized Cerebral Palsy Care

Cerebral palsy (CP) is an intricate brain condition that affects movement and muscle control. More than standard medical care, children with CP need a supportive, creative type of care that transcends a body-focused model, and integrates the emotional and developmental complexities of the child and family. Shriners Children's is among the top of its field, and its emphasis on teamwork is highly regarded for making certain that all of its patients are assured the best possible care regardless of their family's economic condition.

Shriners Children's is more than a pediatric treatment center, but the hope and light to afflicted families with respect to CP. They meld current medicine with therapy, research, and follow-up treatment to create customized care plans to enable each child to be more independent and mobile. Behind their efforts is genuine concern about children and their families.

As President of Shriners Children's, Dr. Leslie D. Stewart presides over the health care system that ventures into this precious work with fire in belly and vision infused by fairness and innovation. Dr. Gaby Martinez, MD, a top pediatric specialist at Shriners Children's Chicago, one of over 30 in the global health care network, illustrates the cooperation and expertise that makes the CP program at the organization one of the most successful in the country. Their efforts highlight the difference that Shriners Children's makes in and what the future for treating children with neurological problems holds.

Let's take a look at Shriners Children's innovative, family-centered strategy to enhance the outcomes of children with cerebral palsy!

A Mission-Driven Leadership With Heart

Dr. Leslie Stewart's leadership at Shriners Children's is deeply connected to the company's fundamental mission: providing life-changing care to each child, regardless of the family's income. Dr. Stewart speaks to this calling with heartfelt sincerity, observing, "My passion for leading Shriners Children's is deeply rooted in our mission—providing life-changing care regardless of a family's ability to pay." This central value goes beyond normal healthcare provision and infuses every facet of the organization's operations.

What inspires Dr. Leslie Stewart every day is the extraordinary commitment of the multidisciplinary teams—doctors, clinicians, researchers, and support staff—uniting behind a single-minded commitment to enabling children with cerebral palsy to reach their highest potential. He stresses, "The complexity of care they need commands not just medical excellence, but compassion, innovation, and long-term partnership with families." This holistic, patient-focused ideology distinguishes the organization in a profession frequently hemmed in by disintegrated models of care.

For Dr. Leslie Stewart, being the leader of Shriners Children's is not simply an executive position; it is a deep commitment and a personal vocation. "To be charged with guiding this organization is not simply a job—it's a calling," he describes. It reflects the intensity of dedication that impels Shriners Children's mission and its extraordinary results in cerebral palsy treatment.

The Mission That Drives Innovation and Compassion

Shriners Children’s reputation for excellence in cerebral palsy care stems from a steadfast commitment to combining compassion with cutting-edge innovation. Dr. Leslie Stewart highlights how the organization’s integrated model harnesses diverse medical expertise alongside rehabilitative therapy and rigorous research to offer life-changing treatments. “Our commitment to excellence in cerebral palsy care stems from the life-changing impact we’ve seen through our interdisciplinary approach, combining advanced medical treatment with rehabilitative therapy, research, and long-term support,” he explains.

For Dr. Stewart, the real reward comes in seeing the resilience and milestones of young patients, each step a testament to the organization's difference. He shares the powerful moments: "Every milestone—no matter how small—is a powerful reminder of why we do what we do.". It could be taking a baseball off the tee for the first time, walking unaided with a bipedal gait, holding and using a cell phone, and other simple accomplishments we just take for granted." These daily accomplishments are characteristic of hope, mobility, and independence that the care at Shriners Children's works to bring about.

This sense of purpose continuously fuels the organization’s efforts to innovate, collaborate with leading experts, and maintain its role as a trailblazer in pediatric neurological care. “We’re not just treating a condition; we’re empowering children and families with hope, mobility, and independence,” Dr. Leslie Stewart affirms. Such a holistic approach exemplifies the organization’s ethos: to treat children as whole individuals, not just their diagnoses.

A Truly Integrated and Patient-Centered Model

What sets the model of cerebral palsy treatment at Shriners Children's apart and makes it successful is its intensely integrated, patient-centered model. Dr. Leslie Stewart explains how the organization assembles a multidisciplinary team of pediatric experts—orthopedic surgeons, neurologists, physical and occupational therapists, motion analysis specialists, and prosthetists—who work in close coordination to create customized care plans. "We assemble a multidisciplinary group of pediatric professionals, all working under one roof to create customized care plans that change as the child grows," he adds.

The collaborative model guarantees that all aspects of a child's life—physical, emotional, and functional—are carefully considered and addressed. Among the organization's technological pillars is its Motion Analysis Centers, where data-driven information permits clinicians to personalize surgical and therapeutic treatments with unprecedented specificity. "We also use top-of-the-line tools such as our motion analysis centers that give us data-driven information that allows us to customize surgical and therapy interventions for optimal results," says Dr. Leslie Stewart. Furthermore, the experience with Shriners Children's goes far beyond standalone procedures or sessions of therapy. The organization's dedication to continuity of care and empathetic involvement fosters a nurturing situation for families during their extended course of treatment. "We don't stop caring with a procedure or therapy visit—it's an ongoing journey we share with our patients and families for years to come," says Dr. Stewart. This long-term continuity, paired with an environment of research and innovation, solidifies the institution as a pediatric cerebral palsy leader in care.

Breakthroughs with Substance Through Patient-Centered Relationships

To Dr. Martinez, the greatest rewards are achieved by establishing strong, trusting relationships with patients and their families. Looking back, she recalls a particular experience that emphasizes the value of trust and patient participation in successful cerebral palsy treatment.

Dr. Martinez relates an early experience with a patient who was referred solely for Botox injections with general anesthesia. But she prefers to do these procedures under just local numbing cream and cold spray in a clinic environment, which was a source of tension with the family initially. To compromise with the family, she organized light sedation by an intensivist, although the experience was traumatic for the child. During follow-up visits, as rapport had been built, the family permitted Dr. Martinez to administer the injections in the office, accompanied by nursing and child life staff offering distraction. "Fast forward to today and this family invites me to his sled hockey games on the weekend and trusts me 100% with his care," she remembers.

This case demonstrates how communication, empathy, and perseverance are as important as medical treatments in the management of cerebral palsy. This patient-centered relationship is central to long-term treatment success and family empowerment.

Overcoming Challenges with Compassion and Creativity

Managing cerebral palsy is very challenging, especially when explaining realistic expectations to families. Dr. Martinez mentions one of the most challenging parts: how to explain that a child's prognosis for walking independently is diminished. "Lots of times children are referred to Shriners first to be seen by one of the orthopedic surgeons because they might have surgery on their hips or spine and sometimes families believe that after surgery their child will walk," she says.

Although surgery may enhance mobility for a few, independent walking is not assured, particularly when weakness in the core muscles is an obstruction. Handling this sensitively and keeping expectations in check demands patience and empathy. When families become aware of the realities, they usually welcome collaborative therapy work and assistive devices promoting their child's mobility. "One large barrier to walking is weakness in the core/trunk muscles.". Families recognize that their child can accomplish standing and walking on their own terms with a support device or braces," Martinez explains.

By shifting the focus on these obstacles to one of improving quality of life through tailored supports, the team creates a healthy optimism and enables families to become active participants in their child's development.

Staying Ahead Through Research and Technology

Innovation continues to be at the center of the organization's strategy for improving cerebral palsy treatment. Dr. Martinez outlines how research throughout the healthcare system uses the depth and scope of the patient database to follow outcomes throughout a lifetime, allowing evidence-based modification of treatment protocols. This longitudinal data of extensive breadth is a rare resource that allows for continuous optimization of care.

One of the most promising frontiers is the use of spinal stimulation to enhance lower limb function and, as a potential result, walking. "Our therapists are learning about the use of, and starting to apply spinal stimulation to attempt to strengthen lower extremity function and thereby potentially enhance walking ability," says Martinez. This is one example of how the institution is pushing the boundaries of care by combining new technologies with old.

In addition, close coordination between the rehabilitation team and orthopedic surgeons makes certain that extensive care is offered prior to, during, and after operations. Anticipatory management optimizes mobility and functional status as children move through stages of treatment. "When a child with CP needs Orthopedic surgery we project their rehabilitation needs ahead of time even before they have a surgery date so that we can enhance their mobility and function as early as possible when they can begin to bear weight on their legs," Martinez states.

A World-Leading Motion Analysis Network

A revolutionary achievement in the health system is the consolidation of 14 Motion Analysis Centers (MACs) in the network, forming the world's largest pediatric motion analysis partnership. This connectivity creates seamless sharing of data among clinicians, coordinating care and speeding research.

"Our Motion Analysis Center is networked with all 14 MACs throughout the Shriners Children's system, making it the world's largest comprehensive pediatric motion analysis center in the world," Martinez points out. Such unprecedented collaboration allows physicians throughout the system to learn from shared experiences, guide future care, and advance research boundaries.

The MACs are essential to the objective evaluation of walking capabilities and the direction of individualized interventions of bracing, therapy, and surgery. This combination of objective information with clinical wisdom is reflective of the organization's dedication to precision medicine and outcomes-based care.

Individualizing Treatment for Each Individual Child

Knowing that every child with cerebral palsy has the same exact needs, Shriners Children's places a strong focus on individualized treatment plans built from extensive assessments. Dr. Martinez is adamant that having sufficient time with patients helps her thoroughly consider their particular situations. "Because the Shriners system focuses on the patient first and foremost, we can spend whatever time is required to evaluate and treat each child's needs fully," she says.

This patient-centered philosophy provides for careful, interdisciplinary care plans that are uniform across the staff but individually tailored to each child. Having the ability to commit this level of care sets the organization apart from those with time pressures and the need for standardization. It demonstrates an immense respect for the uniqueness and multifaceted nature of each child's process.

Exciting Horizons

Looking ahead, Shriners Children's is poised to offer more with promising initiatives like a spinal stimulation program intended to enhance lower extremity motor function. Dr. Martinez points out that a number of therapists have recently undergone training to administer this advanced treatment within the physical therapy department. This development has the potential to greatly maximize standing and walking abilities for children with cerebral palsy.

In addition to this, the incorporation of the digital motion analysis network is a revolutionary step in the right direction. "This revolutionary new innovation at Shriners will allow physicians throughout our entire healthcare system to more easily share information, learn from previous patient outcomes, inform future treatment decisions, and conduct state-of-the-art research," Martinez states. Not only do these innovations improve clinical care, but they raise the bar for pediatric neurological research as well.

Wisdom from Leaders Dedicated to Making a Difference

Dr. Stewart provides genuine advice to healthcare providers who want to make a significant difference in the lives of children. His counsel revolves around not losing empathy and remembering the human being behind every medical chart. "My number one piece of advice for healthcare providers wanting to make a real impact on children's lives is straightforward: never forget the child behind the chart," he states. He emphasizes the importance of teamwork, empathy, and continuous dedication to fairness. "When care is rooted in purpose and given from the heart, the effect can endure for a lifetime—not only for the child, but for their whole family."

Dr. Martinez reaffirms the significance of connection, especially with the child themselves. She invites providers to recognize the child as the focus of every interaction, irrespective of physical or verbal abilities. "Always ask them what their preferred name is and use their name. It matters because you make them feel that they are important to you and you are there to assist them in becoming as independent as possible and enable them to have the best quality of life," she says. This direct interaction promotes trust and dignity, essential elements of effective pediatric care.

A Model of Compassionate Innovation

Shriners Children's is at the forefront of cerebral palsy care by uniting empathetic treatment, collaboration, and innovation. Under the guidance of Dr. Stewart and Dr. Martinez, they deliver customized, evidence-based care putting children and families above all else.

Their cutting-edge programs, such as motion analysis and spinal stimulation, are centered on every child's individual needs and possibilities. The trust and resilience generated here demonstrate a healthcare system genuinely family-centered.

As they develop and thrive, Shriners Children's continues to provide specialized care, hope, and the opportunity for more independence for children with cerebral palsy.

Vaibhavi Choksi: Redefining Leadership Through Purpose, Empowerment, and Innovation in Pharma

True leadership isn’t about chasing headlines or the next big breakthrough. It’s about standing firm in one’s values, cultivating growth in others, and making thoughtful choices that create long-lasting impact. In a world often obsessed with speed and visibility, leaders like Vaibhavi Choksi show us that meaningful progress comes from staying grounded—putting people first and fostering environments where teams can thrive.

A Journey Shaped by Resilience and Serendipity

Vaibhavi’s entry into the pharmaceutical world wasn’t part of a long-standing plan. Despite coming from a family of physicians, she always gravitated toward business. Aiming for an MBA, her path was suddenly altered by a serious accident just days before her entrance exam. What seemed like a major setback led her instead to an unexpected opportunity with Glaxo (now GSK). Drawing from her well-rounded general knowledge and innate curiosity, she stood out and began her career as a medical representative—a move her parents doubted, but one that ultimately defined her future.

Learning Leadership Beyond the Classroom

Her leadership foundation was further strengthened by her education at MIT Sloan School of Management. The case-based learning approach, peer collaboration, and exposure to global leadership experiences transformed her perspective. She was particularly moved by how top leaders shared stories of failure as stepping stones—instilling in her a leadership style rooted in openness, debate, and inclusion.

Leadership from the Ground Up

Rather than a conventional climb, Vaibhavi’s rise was organic—built on hands-on experience and merit. She started in field sales, worked across geographies, and by 2012, held full P&L responsibility. Her leadership philosophy is grounded in execution, inspiration, and accountability. At AstraZeneca, she turned around a struggling oncology division—elevating it from 17th to the top 3 through ambition, strategy, and persistence.

A Front-Row Seat to Industry Transformation

Over two decades, she has witnessed the Indian pharmaceutical landscape evolve—especially post-COVID. Access to care has expanded into Tier 2 and Tier 3 cities, and pharma companies have had to rethink their engagement and education strategies. She notes the growing willingness of non-metro physicians to learn and adapt, pushing companies to innovate beyond product launches.

Innovation Rooted in Practical Impact

To Vaibhavi, innovation isn't only about science; it’s about mindset. She’s known for pioneering strategic initiatives—like building a diagnostics network for lung cancer patients or generating nearly 40% revenue from the complex government sector. Her leadership in Germany helped transform India from a distributor-led model to a full affiliate, making it a global priority market. Whether through data analytics or people development, her innovation philosophy is deeply tied to creating sustainable, scalable systems.

Breaking Gender Barriers

One of her most notable achievements has been paving the way for women in pharmaceutical sales—a traditionally male-dominated field. Facing skepticism and societal resistance, she immersed herself in field work to build credibility. Today, she encourages women to embrace sales as a powerful foundation for understanding real-world healthcare dynamics.

Mentorship as a Leadership Mandate

What matters most to Vaibhavi isn’t titles, but the legacy of empowerment. She takes immense pride in mentoring others—many of whom now hold senior roles. Her ability to spot and nurture talent has been a defining trait, and she sees mentorship not just as guidance but as a shared journey of growth and accountability.

Bridging Access and Affordability

One of her proudest contributions has been driving patient access to cutting-edge treatments without sacrificing affordability. She has championed pricing strategies that make therapies more accessible and even explored innovative financing solutions for cancer patients. Her belief: innovation only matters when it reaches the people who need it.

Addressing the Overlooked: Nutrition in Cancer Care

Recognizing that recovery isn’t just medical, she launched a free, multilingual cancer patient recipe book—distributing it through doctors and integrating it into treatment discussions. The initiative, done in partnership with The Economic Times, evolved into a digital module, seamlessly blending nutrition with clinical care.

The Power of Letting Go

Perhaps one of her most important leadership lessons is knowing when to pivot. In a culture where quitting is often seen as weakness, Vaibhavi sees it as strength—an opportunity to reallocate energy and focus toward what truly matters.

---

Vaibhavi Choksi’s leadership journey is a masterclass in clarity, compassion, and courage. From field sales to strategic boardrooms, from grassroots mentorship to global market transformation, she has consistently redefined what it means to lead in pharma. Her story is not just one of personal success—it is a blueprint for building resilient teams, inclusive cultures, and a healthcare ecosystem that puts people first.

#WomenInLeadership #PharmaInnovation #EmpoweredLeadership #PatientFirst #MentorshipMatters #InclusiveHealthcare #BusinessWithPurpose

Élodie Duperchy: Visionary Leadership, Innovation, and Compassion in Aesthetic Medicine

In the constantly changing Swiss healthcare environment, where innovation and regulation meet, Élodie Duperchy stands out. As Country Manager of Cutera, a world leader in medical aesthetic devices, Élodie is transforming the convergence of beauty and healthcare. With a background that comfortably bridges clinical science and luxury beauty, she has become a trusted authority on medical aesthetics and a leading voice in Switzerland's revolutionizing of healthcare.

From Beauty to Medical Innovation: A Special Experience

Élodie's journey to healthcare leadership started in the worlds of perfume and cosmetics. With more than 15 years of experience with top brands such as Henkel and LVMH, she established a good foundation in business operations, brand strategy, and understanding consumers. But her passion for deeper, more meaningful work pushed her to find the clinical aspect of beauty.

Her journey started at UNILABS, a clinical analysis laboratory, where she was intrigued by the science of skin and beauty. She was then drawn to Teoxane, a Genevan company producing aesthetic fillers, where she could explore medical skincare and develop solid relationships with the aesthetic medicine community.

When Cutera came calling, she welcomed the chance to be at the helm of medical technology. "I viewed it as an opportunity to meld all my experience—scientific, strategic, and relational—into one compelling role," she recalls.

A Value-Based Mission Rooted in Relationship

As a Country Manager, Élodie is more interested in having a lasting impact, rather than mere growth. She constructs leadership on genuine partnership rather than transactional achievement. "To me, it's never about just achieving sales targets. It's about delivering long-term value, strategic counsel, and guidance that is aligned with our clients' changing objectives," she says.

One of her first initiatives at Cutera Switzerland was to understand thoroughly client aspirations and challenges. "Every clinic or doctor has a unique story. Our job is to listen carefully and provide tailored solutions that align with their future," she says.

This commitment has enabled Cutera to be a genuine partner in the aesthetic market, not only providing machinery but also advice, training, and cooperative support.

Managing Regulation in Advance

Switzerland's medical landscape is marked by a complex and demanding governing system—something Élodie navigates with prescience and lucidity. Perhaps one of the most demanding challenges she had to overcome was the 2019 regulation of laser use in aesthetics, which will be fully implemented in 2024.

"Medical aesthetics isn't formally a recognized specialty in Switzerland, which leaves things in a gray area," Élodie explains. In response, she and her team centered on training programs to keep doctors and practitioners compliant without compromising quality of care.

It's our responsibility not just to provide the best technology but to also teach our clients how to use it responsibly," she says. By partnering with certified schools of training and regulatory agencies, Cutera under her leadership ensures compliance and innovation go hand in hand.

Trust, Teamwork, and Leadership in Action

Trust is the foundation of Élodie's leadership—both within her own team and with clients. She fosters an atmosphere of openness and collaboration, beginning by unifying disparate internal departments around a common purpose.

When I joined, I brought together technical, clinical, and marketing personnel. Once we had an understanding of each other's language and mission, we created synergy—and that energy transferred to our customers," she says.

Her caring, human-oriented approach was especially essential amidst the COVID-19 crisis. In times of uncertainty, Élodie centered on consistency and communication, keeping morale up and clients comfortable. "In times of uncertainty, people are looking for stability. That's when true leadership really comes through," she says.

Revolutionizing Acne Treatment with Aviclear One benchmark success while working under the guidance of Élodie at Cutera has been the launch success of Aviclear—the first FDA-cleared energy device to treat mild to severe acne. Aviclear applies a 1726 nm wavelength to penetrate and inhibit sebaceous glands, providing a non-surgical alternative to conventional acne treatments.

"It's a real breakthrough," insists Élodie. "Three treatments can really cut acne down, transforming lives—particularly for younger patients who are fighting problems of self-esteem."

The innovation means more than clinical success; it means her desire to provide meaningful, science-based answers that reach deeper than the surface of lives.

Embracing Digital Technologies to Enhance Excellence

Cutera's emphasis on digitalization is also driving Élodie's strategy. From Salesforce CRM to cutting-edge field service software such as Outsmart, digital platforms make operations more efficient and improve customer service.

Our newest equipment is connected in a network, enabling real-time support and diagnostics," she states. Remote access saves downtime, reduces expenses, and enhances client satisfaction. "Technology enables us to be smarter, more efficient, and faster—without sacrificing the human touch.".

Balancing Innovation with Compliance

Introducing sophisticated medical technology into Switzerland involves strict adherence to domestic laws. Luckily, a recent move by the Swiss Federal Council to open up importation of FDA-approved devices is fully in line with Cutera's international standards.

"We're FDA and CE mark compliant for all our equipment, so we're totally compliant in Europe and Switzerland," Élodie guarantees. Scrupulous regulatory care is taken to see that innovation arrives unencumbered to practitioners—and patients.

2025 Leadership: Clear Vision, People Connection

To Élodie, 2025 leadership is all about motivating others and leading organizations through change and complexity. "Doctors, clinics, and businesses all need leaders who can adapt, inspire, and lead people through uncharted territory," she says.

Ongoing learning is not optional. "The market is in constant motion. Yesterday's solution may not be the answer tomorrow. Listening is key—both to the market and to the folks who are propelling it.".

Her leadership style is vision, humility, and strategic agility, rooted in authenticity. A Message for Upcoming Leaders: Remain Authentic to Yourself As a female executive in a highly technical, male-dominated field, Élodie has some advice for aspiring leaders: be yourself. "Listen to advice, yes—but trust your heart, your instincts, and hold on to your values," she advises. She quotes Napoleon Hill: "Whatever the mind can conceive and believe, it can achieve." Élodie is convinced that genuine leadership generates strength, power, and clarity. "If you lead from a place of truth, everything flows—even in the midst of adversity," she summarizes.

Khaled Sary: Enabling Health Innovation to Create a Sustainable Legacy

 

Good leaders are future-focused, not only to what is occurring presently, but to what can occur in the future. Their capacity to move beyond the moment enables them to initiate future actions that produce improved results. In medicine, this type of thinking is crucial because the medical field is continually evolving. Today's healthcare sector requires leadership that finds creative solutions to develop improved conditions of life.

Khaled Sary, General Manager of the West Gulf Cluster of Takeda, is amongst such leaders. Through years of sincere service, he has relentlessly worked on improving the delivery of healthcare, bringing about changes that have worked for good for not only his peers but also the patients. His leadership extends beyond business growth towards paving a better and healthier future for all.

With his unrelenting commitment to healthcare and extensive pharmaceutical knowledge, he has led Takeda's business in the Middle East, particularly through the West Gulf Cluster. By his professional progress, Dr. Khaled Sary shows the worth of total devotion and adaptable thinking combined with human-oriented methods of medical growth.

Dr. Khaled Sary's leadership style at Takeda reflects total commitment to both patient care outcomes and organizational excellence. He keeps the organization in pursuit of further enhancing the pharmaceutical market in the region through conducting awareness and learning projects for the therapeutic areas, such as Gastrointestinal and Immunology, Rare diseases, Oncology, and Vaccines.

Let us take a look below Khaled's career path, leadership values, and the transformation Takeda has experienced under his guidance in the Middle East!

A Journey of Growth

Dr. Sary's career in the pharma industry has been nothing but revolutionary. He began with a strong love of health care that dictated his career from the very beginning. His early career was initially guided by his training as a physician, but his ambition went far beyond practicing medicine. He was attracted to the larger effect healthcare leadership could have on society.

His working life initially began in Egypt, where he initially worked as a medical representative. This gave him a good footing in the pharmaceutical sector, as he was able to understand the dynamics of sales, marketing, and healthcare solutions. His career really gained momentum, though, in 2001 when he moved to Saudi Arabia. He held different positions over the years, among them Sales and Marketing Manager and Business Unit Head. His inputs in the above positions earned him valuable knowledge about the region's pharmaceutical industry, including the effect of mega-mergers, like the Schering-Plough and MSD merger, which remodeled the industry.

His experience in Saudi Arabia was characterized by the relentless transformation of the industry, a time in which he became aware of the power of transformation in the healthcare sector through innovation. This awareness pushed him to work with Takeda Pharmaceuticals as a Business Unit Manager, a position that would shape the second part of his professional life. "Joining Takeda was a turning point," he remembers. It enabled me to merge my medical experience with leadership skills to lead meaningful initiatives that fit with Takeda's mission.

Currently, as General Manager of West Gulf Cluster, Dr. Khaled Sary directs operations in Saudi Arabia, Qatar, Oman, and Bahrain. His experience through different leadership positions in the Gulf has given him the expertise and foresight required to guide the company's operations and its goal of providing high-quality healthcare solutions.

Leadership Philosophy: Teamwork, Innovation, and Patient-Focused Care

Khaled Sary's leadership style is rooted in teamwork, innovation, and a patient-first culture. The patient focus is central not just to Takeda's decision-making process, but to his personal worldview. He feels it is necessary to foster a culture that allows ideas to thrive and where many different points of view are welcomed. "Empowering teams to bring their best ideas forward is crucial," he maintains. “This approach allows us to navigate the ever-evolving pharmaceutical industry while ensuring our strategies align with both local needs and global standards.”

His philosophy has made a big difference in the way Takeda works in the Middle East. He has worked hard to establish a culture of trust, transparency, and integrity, which has resulted in robust partnerships within the organization as well as with stakeholders outside. By giving highest importance to these values, he has been able to make Takeda a strategic partner for healthcare authorities across the region, dedicated to enhancing patient outcomes.

In addition, his emphasis on teamwork is not limited to internal units but also encompasses collaborations with regional healthcare entities. He is aware of the need for establishing relationships that are founded on respect and trust for one another. "Our leadership style is not only about getting things done; it's about getting things done in a manner that is collaborative, transparent, and integrity-driven," he expounds.

Takeda's Role in Transforming Healthcare in the Region

Takeda's contribution towards shaping the future of healthcare in the Middle East lies in its focus on innovative treatments and medicines. The company is spearheading substantial progress under his leadership in therapeutic areas including Gastrointestinal and Immunology, Rare diseases, Oncology, and Vaccines—areas that are going to shape the future of healthcare in the region. "We see ourselves as important drivers of improving access to life-changing medicines, thus improving patient care and outcomes," he says.

One key priority that Dr. Khaled Sary is concentrating on is building alliances with regional healthcare organizations. Through close collaboration with these stakeholders, Takeda seeks to enhance patient access and treatment delivery in several different therapeutic zones. "Working closely with healthcare authorities is at the core of what we do. We believe that healthcare innovation starts with robust partnerships that drive better timely diagnoses and more efficient treatment approaches.". Together, we can deliver revolutionary change and better outcomes for patients around the globe." He stated.

Besides these collaborations, the organization is also heavily investing in education initiatives. Khaled's department has created programs to spread awareness and comprehension of intricate diseases, pushing its mission of patient-first care. Digital health is also a major area of investment. By embedding digital technologies in healthcare delivery, Takeda is improving patient engagement and operationalizing efficiency. "Digital health is a compelling opportunity," he maintains. "It enables us to properly engage with our patients in quicker and new ways and enhance the patient experience overall." 

Challenges and Opportunities in the Middle East Healthcare Landscape

The Middle Eastern healthcare environment is changing very quickly, bringing challenges as well as opportunities to players such as Takeda. One of the greatest challenges he foresees is making sophisticated healthcare solutions available across the region's varied regulatory and economic environments. "The regulatory landscape is very different from country to country," he says. "Working through these distinctions takes smart partnership with government agencies, healthcare providers, and pharmaceutical firms.

Meanwhile, Dr. Khaled Sary sees these challenges as opportunity for innovation and expansion. The company's capacity to learn and adjust to these diverse terrains has enabled the company to make huge strides in expanding patient access to innovative treatments. He also considers digital transformation as a huge opportunity. "Digital transformation is not only about enhancing operations—it's about enhancing the delivery of healthcare," he says. "Digital health solutions make it possible for us to communicate with patients in more personalized and effective ways."

Advancements and Strategies to Enhance Patient Care

Khaled Sary is also keen on the change that Takeda is leading to enhance patient care. One of the main areas of emphasis is the discovery of innovative treatments in Gastrointestinal and Immunology, Rare Diseases, Oncology and Vaccines. "We are dedicated to pioneering innovation in these difficult-to-treat therapeutic areas, which remain a central pillar of our purpose in bringing healthcare progress to the region." he added.

Aside from these research and development initiatives, the company is incorporating digital health technologies to support more active patient engagement. "With the aid of digital tools, we can provide more personalized healthcare experiences," he continues. "This convergence of technology enables us to fill gaps in access to healthcare and enhance the outcomes of patients."

Proudest Achievements

Khaled Sary looks back at some of the major highlights throughout his time at Takeda, but also says one of the most noteworthy is its evolution in patient engagement through the development of a number of influential events. "The introduction of differentiated platforms such as IBD Aware, HAE Summit, and IBD Nexus has been a career highlight for me," he explained. "These events have established important platforms for conversation and collaboration between healthcare professionals, patient communities, and stakeholders."

These incidents not only raised awareness in key therapeutic fields like inflammatory bowel disease (IBD) and hereditary angioedema (HAE), but have also facilitated cooperation among different healthcare professionals. He is further delighted with the inauguration of Takeda's Riyadh Regional Headquarters, marking a strategic move to enhance its presence in the region. “This new hub is a testament to our commitment to long-term partnerships and our vision of strengthening regional integration,” he says.

Balancing Corporate Success with Patient Well-Being

For Dr. Khaled Sary, the delicate balance between corporate success and patient welfare is the cornerstone of his leadership style. "Our strategy for growth fits with the necessity to bring life-changing medicines meeting well with the needs of patients," he explains. The corporate growth strategy of the organization is grounded in sustainability, keeping business success inextricably linked with a good impact on society.

Takeda West Gulf's dedication to increasing health care access in under-served communities is a prime example of how the company strikes a balance between these two goals. "Growth of the business is valuable, but always tied to values of society," he stresses. Through patient assistance programs and partnerships with healthcare providers, Takeda is having a positive impact on the lives of patients who suffer from IBD, HAE and Cancer.

Advice for Emerging Healthcare Professionals

Khaled Sary's message to those who would be healthcare leaders is straightforward but potent: "Always keep yourself curious and never stop learning." To him, the most effective leaders are the ones who are constantly seeking new ways of enhancing patient care, either through technological innovations or novel treatment techniques. "The field of health care is dynamic and ever-changing, and the quality of being adaptable and innovative is extremely important," he recommends.

He also emphasizes collaboration and empathy as a key leadership skill. "In order to make a difference, you must work with people and try to understand them," he says. "The capacity to listen, learn, and act with integrity will stand you apart from the competition in this industry."

As he oversees Takeda Pharmaceuticals in the West Gulf region, his vision for the future is unobscured: to create a healthcare environment that is innovative, patient-focused, and transformative. His leadership serves as a compelling model of what can be achieved by one person to make a lasting difference in the lives of patients and the wider healthcare community.